Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 855

Similar articles for PubMed (Select 17210801)

1.

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM.

Arch Neurol. 2007 Mar;64(3):343-9. Epub 2007 Jan 8.

PMID:
17210801
2.

The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid.

Toombs J, Paterson RW, Nicholas JM, Petzold A, Schott JM, Zetterberg H.

Clin Chem Lab Med. 2015 Jun 23. pii: /j/cclm.ahead-of-print/cclm-2015-0414/cclm-2015-0414.xml. doi: 10.1515/cclm-2015-0414. [Epub ahead of print] No abstract available.

PMID:
26103629
3.

Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.

Rosén C, Farahmand B, Skillbäck T, Nägga K, Mattsson N, Kilander L, Religa D, Wimo A, Blennow K, Winblad B, Zetterberg H, Eriksdotter M.

Alzheimers Dement. 2015 Jun 13. pii: S1552-5260(15)00185-5. doi: 10.1016/j.jalz.2015.04.007. [Epub ahead of print]

PMID:
26079415
4.

Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly.

Amariglio RE, Mormino EC, Pietras AC, Marshall GA, Vannini P, Johnson KA, Sperling RA, Rentz DM.

Neurology. 2015 Jun 5. pii: 10.1212/WNL.0000000000001712. [Epub ahead of print]

PMID:
26048028
5.

Cerebral perfusion in the predementia stages of Alzheimer's disease.

Binnewijzend MA, Benedictus MR, Kuijer JP, van der Flier WM, Teunissen CE, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F.

Eur Radiol. 2015 Jun 5. [Epub ahead of print]

PMID:
26040647
6.

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.

Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc'h K, Sablonnière B, Kastanenka KV, Delaby C, Pasquier F, Touchon J, Hugon J, Paquet C, Lehmann S.

Alzheimers Res Ther. 2015 Jun 1;7(1):30. doi: 10.1186/s13195-015-0114-5. eCollection 2015.

7.

Absence of Practice Effects in Preclinical Alzheimer's Disease.

Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC.

Neuropsychology. 2015 May 25. [Epub ahead of print]

PMID:
26011114
8.

Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models.

Maia LF, Kaeser SA, Reichwald J, Lambert M, Obermüller U, Schelle J, Odenthal J, Martus P, Staufenbiel M, Jucker M.

EMBO Mol Med. 2015 May 15. pii: e201505026. doi: 10.15252/emmm.201505026. [Epub ahead of print]

9.

Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.

Rolstad S, Jakobsson J, Sellgren C, Ekman CJ, Blennow K, Zetterberg H, Pålsson E, Landén M.

PLoS One. 2015 May 8;10(5):e0127100. doi: 10.1371/journal.pone.0127100. eCollection 2015.

10.

Alternative neural circuitry that might be impaired in the development of Alzheimer disease.

Avila J, Perry G, Strange BA, Hernandez F.

Front Neurosci. 2015 Apr 23;9:145. doi: 10.3389/fnins.2015.00145. eCollection 2015. Review.

11.

Reduced CSF Water Influx in Alzheimer's Disease Supporting the β-Amyloid Clearance Hypothesis.

Suzuki Y, Nakamura Y, Yamada K, Igarashi H, Kasuga K, Yokoyama Y, Ikeuchi T, Nishizawa M, Kwee IL, Nakada T.

PLoS One. 2015 May 6;10(5):e0123708. doi: 10.1371/journal.pone.0123708. eCollection 2015.

12.

d-serine levels in Alzheimer's disease: implications for novel biomarker development.

Madeira C, Lourenco MV, Vargas-Lopes C, Suemoto CK, Brandão CO, Reis T, Leite RE, Laks J, Jacob-Filho W, Pasqualucci CA, Grinberg LT, Ferreira ST, Panizzutti R.

Transl Psychiatry. 2015 May 5;5:e561. doi: 10.1038/tp.2015.52.

13.

Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.

Fonteh AN, Ormseth C, Chiang J, Cipolla M, Arakaki X, Harrington MG.

PLoS One. 2015 May 4;10(5):e0125597. doi: 10.1371/journal.pone.0125597. eCollection 2015.

14.

Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments.

Mothapo KM, Stelma F, Janssen M, Kessels R, Miners S, Verbeek MM, Koopmans P, van der Ven A.

J Neuroimmunol. 2015 May 15;282:73-9. doi: 10.1016/j.jneuroim.2015.03.017. Epub 2015 Mar 21.

PMID:
25903731
15.

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.

Sweeney MD, Sagare AP, Zlokovic BV.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1055-68. doi: 10.1038/jcbfm.2015.76. Epub 2015 Apr 22. Review.

PMID:
25899298
16.

Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.

Almeida RP, Schultz SA, Austin BP, Boots EA, Dowling NM, Gleason CE, Bendlin BB, Sager MA, Hermann BP, Zetterberg H, Carlsson CM, Johnson SC, Asthana S, Okonkwo OC.

JAMA Neurol. 2015 Jun 1;72(6):699-706. doi: 10.1001/jamaneurol.2015.0098.

PMID:
25893879
17.

Trajectory of Mobility Decline by Type of Dementia.

Tolea MI, Morris JC, Galvin JE.

Alzheimer Dis Assoc Disord. 2015 Apr 4. [Epub ahead of print]

PMID:
25886717
18.

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.

Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ.

BMC Neurol. 2015 Apr 1;15:51. doi: 10.1186/s12883-015-0298-0.

19.

Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.

Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM.

JAMA Neurol. 2015 Jun 1;72(6):656-65. doi: 10.1001/jamaneurol.2015.0202.

PMID:
25867677
20.

Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.

Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, Edland SD, Salmon DP, Galasko DR, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative Investigators.

JAMA Neurol. 2015 May 1;72(5):546-53. doi: 10.1001/jamaneurol.2014.4477.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk